Unfortunately, the prognosis remains poor, with a median overall survival (mOS) of 20.9 months and a median progression-free survival (mPFS) of 6.7 months ( Here, we will discuss the previously explored repurposing efforts in the treatment of GB based on targeting two of the three most altered signal transduction pathways in GB: Receptor tyrosine kinase (RTK) and cyclin-dependent kinase (CDK)-retinoblastoma (Rb) ( Despite an increased understanding of GB tumor biology with discoveries of potential targets, the unique challenges posed by this aggressive tumor continue to thwart treatment benefits
Eight hours later, it primarily accumulated in the tumor region, whereas free Sulfo-Cyanine7 exhibited a systemic distribution
We also used a competitive antigen-specific, T cell receptor (TCR)-dependent proliferation assay (OT-II) and a competitive homeostatic proliferation assay to assess T cell proliferation and differentiation in vivo
SAAR increased pyruvate, decreased malate (WT mice only), and elevated aspartate (Fig
Surgical lens extraction remains the standard treatment, which, despite its effectiveness, carries potential postoperative risks and economic burdens, thereby underscoring the need for alternative, non-surgical therapeutic approaches
All participants received 600 mg ALA orally per day for 4 weeks and were instructed not to receive any drug that relieves neuropathic pain